Facebook-f Twitter Linkedin Youtube
SUBSCRIBE
Facebook-f Twitter Linkedin Youtube
SUBSCRIBE

Neuroscience blog

View Details

Improving the Management of Chronic Neurodegenerative Diseases with Interprofessional Collaboration & Care

Multiple sclerosis (MS) and Parkinson’s disease (PD) are 2 highly prevalent chronic progressive neurodegenerative disorders. Over time, the accumulation and subsequent worsening of the symptoms associated with these diseases can result in disability, impaired quality of life, loss of independence, and an increased burden on caregivers.  
  • Neuroscience
  • Blog
DOWNLOAD
View Details

New Treatments for SMA: Should We Offer Them to Adults?

Spinal muscular atrophy (SMA) is a genetic disorder and a devastating diagnosis for children and their families that can lead to death or a lifetime of severe disability and progressively limited mobility.
  • Neuroscience
  • Blog
DOWNLOAD

RMEI DECISION SUPPORT AIDS

View Details

The Evolving Role of Orexin-Based Therapy in Narcolepsy Type 1 Management

This Decision Support Aid serves as a quick reference to help clinicians to apply information to their daily practice and care of patients.
  • Neuroscience
  • Decision Support Aid
DOWNLOAD
View Details

Clearing the Path for the Accurate Diagnosis and Optimal Treatment of Bipolar Depression: A Clinical Convergence®

This Decision Support Aid serves as a quick reference to help clinicians to apply information to their daily practice and care of patients.
  • Neuroscience, Psychiatry
  • Decision Support Aid
DOWNLOAD

LATEST NEUROSCIENCE ARTICLES

RSS Latest Neuroscience Articles
  • Cardiotoxic Effects and Microdystrophin Expression after Gene Therapy for DMD August 6, 2026
    In a patient with Duchenne muscular dystrophy, cardiotoxic effects developed after treatment with delandistrogene moxeparvovec. Microdystrophin levels in the heart and skeletal muscle were less than 1% of normal dystrophin levels.
    Benjamin J. Samelson-Jones, Cristina Martos-Rus, Carolyn M. Yrigollen, Luis Tecedor, Juliana C. Small, Susan E. Matesanz, Connor T. Watson, Andrew R. Vanden Heuvel, Sean Carrig, Sabrina W. Yum, John F. Brandsema, Kimberly Lin, Carol Wittlieb-Weber, Angela N. Viaene, Pierre P. Russo, Sara Partington, Katie Huynh, Tiffany Seneviratne, Silvia Juarez Rojas, Bhavya S. Doshi, Perry Shieh, Kevin M. Flanigan, Emma Frair, Stefan Nicolau, Michael W. Lawlor, Julie M. Crudele, Beverly L. Davidson, Lindsey A. George
  • Syncope August 6, 2026
    This review summarizes the classification, evaluation, risk stratification, and management of syncope. History, examination, electrocardiography, and orthostatic blood-pressure measurement identify the cause in most patients.
    Rose Anne Kenny
  • Oxygen Targets after Cardiac Arrest — A LOGICAL Finding August 6, 2026
    In unresponsive patients after cardiac arrest, a complex pathophysiological response including potential brain injury, myocardial dysfunction, and systemic ischemia–reperfusion injury is at play, in addition to the challenges of the underlying cause of cardiac arrest.1 This complex and unique, but heterogeneous, constellation has prompted clinicians and researchers to...
    Lars W. Andersen, Asger Granfeldt

RMEI LIGHTNING TALKS

View Details

4 Years, 16 Live & Online Activities, 6000+ Clinicians: What we've learned so far

RMEI has released pairings of live and online programs approximately twice per year since 2016 grouped into “phases” which share clinical areas of focus and are based on findings from the previous phase of education. In total, 16 activities have launched to date with 4 activities currently live. The purpose of this analysis is to better understand the impact of multi-year iterative education on a clinical audience. Presented at: Society for Academic CME (SACME), virtual, February 2021; Accreditation Council for Continuing Medical Education (ACCME), virtual, April 2021.
  • Allergy & Immunology
  • 2021
View Details

Effectiveness of 5-year IBD Provider Online Educational Intervention Program

There is considerable practice variability among providers caring for inflammatory bowel disease (IBD) patients. Limited data exists on the effectiveness of educational interventions targeting IBD providers to address these gaps. We report outcomes for a 5-year provider education training program which culminated in an enduring online education resource and clinical decision support tool.
  • Gastroenterology
  • 2021

Previously Published CE Activities